Fig. 1. Characterization of iPSC cardiomyocytes generated from donor (D) and diseased patient's (PCCD) cells. A. A short scheme representing iPSC cardiomyocytes differentiation. B. Immunostaining of iPSC cardiomyocytes) for desmosome markers desmoplakin (DSP) and plakophilin-2 (PKP2); cytoskeleton marker troponin I type 3 (TNNI3); and DAPI-labeled nuclear DNA.C. Western blot showing expression of DSP and its summarized expression normalized to cardiac troponin T (TNNT2).